Filing Flows › Comparisons › OCGN vs TNYA
Ocugen vs Tenaya Therapeutics: OCGN and TNYA compared
Ocugen is the larger company: $2.0M of revenue in its latest quarter (Q3 2026) against $1.7M for Tenaya Therapeutics (Q3 2026).
Where the money goes: OCGN and TNYA
Ocugen (OCGN) · Q3 2026
Ocugen, Q3 2026: revenue $2.0M (+11% year over year), operating margin -909.9%, net loss $3.6M, operating cash flow −$15.7M. The chart follows the revenue to costs, profit and cash.
Tenaya Therapeutics (TNYA) · Q3 2026
Tenaya Therapeutics, Q3 2026: revenue $1.7M, net loss $18.9M, operating cash flow −$17.7M. The chart follows the revenue to costs, profit and cash.
| Ocugen (OCGN) | Tenaya Therapeutics (TNYA) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $2.0M | $1.7M |
| Revenue growth, Y/Y | +11% | — |
| Operating margin | -909.9% | n/m |
| Net earnings | −$3.6M | −$18.9M |
| Net margin | -184.4% | — |
| Operating cash flow | −$15.7M | −$17.7M |
Questions
Which is bigger, Ocugen or Tenaya Therapeutics?
Ocugen is the larger company: $2.0M of revenue in its latest quarter (Q3 2026) against $1.7M for Tenaya Therapeutics (Q3 2026).
More: Ocugen earnings · how Ocugen makes money · Tenaya Therapeutics earnings · how Tenaya Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.